Skip to main content
logo
GE HealthCare Technologies Inc. (BVC:GEHC)
Colombia flag Colombia · Delayed Price · Currency is COP
289,860
0.00 (0.00%)
At close: Feb 5, 2026

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Product Revenue
13.66B
Service Revenue
6.96B
Revenue (Total)
20.63B

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Imaging Revenue (Post-Q2 2024)
9.25B
Advanced Visualization Solutions (AVS) Revenue
5.35B
Patient Care Solutions (PCS) Revenue
3.09B
Pharmaceutical Diagnostics (PDx) Revenue
2.90B
Other Revenue
40.00M
Revenue (Total)
20.63B

Revenue Breakdown 3

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Patient Care Solutions (PCS) Revenue
3.09B
Pharmaceutical Diagnostics (PDx) Revenue
2.90B
Other Revenue
40.00M
Revenue (Total)
20.63B

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
USCAN Revenue
9.53B
EMEA Revenue
5.43B
China Revenue
2.25B
Rest of World Revenue
3.42B
Revenue (Total)
20.63B

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Imaging EBIT (Post-Q2 2024)
891.00M
Advanced Visualization Solutions (AVS) EBIT
1.18B
Patient Care Solutions (PCS) Segment EBIT
209.00M
Pharmaceutical Diagnostics (PDx) Segment EBIT
872.00M
Other Segment EBIT
7.00M
Operating Income (Other)
-391.00M
Operating Income (Total)
2.76B

EBIT 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Patient Care Solutions (PCS) Segment EBIT
209.00M
Pharmaceutical Diagnostics (PDx) Segment EBIT
872.00M
Other Segment EBIT
7.00M
Operating Income (Total)
2.76B

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Products Remaining Performance Obligations (RPO)
5.00B
Services Remaining Performance Obligations (RPO)
10.73B
Total Remaining Performance Obligations (RPO)
15.73B
Updated Dec 31, 2025. Data Source: Fiscal.ai.